Patent 10443074 was granted and assigned to Inscripta on October, 2019 by the United States Patent and Trademark Office.
The present disclosure provides methods and devices for rapid and efficient modification of a variety of cell types, including mammalian cells, plant cells, archaea, yeasts, and bacteria, by novel methods of introducing exogenous materials, e.g. nucleic acids.